Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
US Army
Daiichi Sankyo
Johnson and Johnson
Colorcon
Accenture
Covington
Medtronic
QuintilesIMS

Generated: April 26, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 074434

« Back to Dashboard

NDA 074434 describes CAPTOPRIL, which is a drug marketed by Apotex, Apothecon, Boscogen, Dava Pharms Inc, Egis Pharms, G And W Labs Inc, Hikma Intl Pharms, Mylan Pharms Inc, Par Pharm, Prinston Inc, Purepac Pharm, Sandoz, Teva, Vintage Pharms Llc, Watson Labs, Wockhardt Ltd, Yaopharma Co Ltd, Ivax Sub Teva Pharms, and Mylan, and is included in twenty-eight NDAs. It is available from twenty-nine suppliers. Additional details are available on the CAPTOPRIL profile page.

The generic ingredient in CAPTOPRIL is captopril; hydrochlorothiazide. There are fifteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the captopril; hydrochlorothiazide profile page.
Summary for 074434
Tradename:CAPTOPRIL
Applicant:Mylan Pharms Inc
Ingredient:captopril
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 074434
Medical Subject Heading (MeSH) Categories for 074434
Suppliers and Packaging for NDA: 074434
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CAPTOPRIL captopril TABLET;ORAL 074434 ANDA Mylan Pharmaceuticals Inc. 0378-3007 N 0378-3007-01
CAPTOPRIL captopril TABLET;ORAL 074434 ANDA Mylan Pharmaceuticals Inc. 0378-3007 N 0378-3007-10

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength12.5MG
Approval Date:Feb 13, 1996TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength25MG
Approval Date:Feb 13, 1996TE:ABRLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength50MG
Approval Date:Feb 13, 1996TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Cantor Fitzgerald
Julphar
Cipla
Fish and Richardson
Citi
AstraZeneca
McKesson
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.